US regulatory status: approved. Molecular target: Adrenergic receptor alpha.
- Target
- Adrenergic receptor alpha
- Mechanism
- Adrenergic receptor alpha antagonist
pharma · Renal Impairment · Osteoarthritis, Knee / Osteoarthritis, Hip
Tanabe Pharma
Tanabe Pharma drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Osaka, JP HQ
1678 Founded
104 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Osaka, JP
- Founded
- 1678
- Employees
- 104
- Programs
- 4
- Drugs
- 1
- Patents
- 0
Tanabe Pharma pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Tanabe Pharma drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.